Related Experiment Videos
Hematologic effects of total knee arthroplasty. A prospective evaluation
1Department of Orthopaedic Surgery, Northwestern University, Chicago, Illinois.
Clinical Orthopaedics and Related Research
|January 1, 1993
Summary
Total knee arthroplasty activates coagulation and fibrinolytic systems, causing significant platelet reduction. Bilateral procedures show more pronounced hematologic changes, warranting careful patient evaluation.
Area of Science:
- Orthopedic Surgery
- Hematology
- Biochemistry
Background:
- Total knee arthroplasty (TKA) is a common orthopedic procedure.
- Perioperative hematologic changes following TKA are not fully understood.
- Coagulation and fibrinolytic system activation may occur during TKA.
Purpose of the Study:
- To investigate perioperative hematologic changes in patients undergoing cemented total knee arthroplasty.
- To compare these changes between unilateral and bilateral procedures.
- To assess the activation of coagulation and fibrinolytic systems.
Main Methods:
- Prospective evaluation of 41 patients (57 knees) undergoing cemented TKA.
- Perioperative blood testing included platelet counts, fibrinogen, and fibrin degradation products (FDP).
- Patients were categorized into unilateral and bilateral procedure groups.
Main Results:
- Postoperative platelet counts significantly decreased (average 32% for unilateral, 64% for bilateral).
- Fibrinogen levels increased significantly (average from 304 mg/dl to 647 mg/dl).
- Fibrin degradation products showed a trend toward greater elevation after bilateral procedures, indicating more pronounced coagulation and fibrinolytic activation.
Conclusions:
- Cemented total knee arthroplasty leads to significant hematologic changes, including thrombocytopenia and activation of coagulation/fibrinolysis.
- Bilateral TKA procedures result in more pronounced hematologic alterations compared to unilateral procedures.
- Preoperative platelet count assessment is crucial for evaluating candidates for bilateral TKA due to the risk of significant thrombocytopenia.